News

Focus on

Eveon (March 2010)

Eveon SAS is a French company founded in December 2008 by 4 associates skilled in injection medical device, microsystems and management. Eveon has just cleared an important stage in its development plan by raising more than 2 million euros.

genOway (Janvier 2010)

GenOway is a biotechnology company developing genetically modified and high value-added research models for the bio-pharmaceutical, chemical, agrochemical and food industry as well as for academic research.

NovoCIB (October 2009)

NovoCIB is a young biotechnology company which was stemmed from the research of new treatments against Hepatitis C Virus (HCV) and has specialized in the study of nucleotide metabolism. Founded in 2005 by Dr Larissa Balakireva, Ph.D. in Cell Biology, the company was twice laureate of the French National Contest for Innovative Companies and laureate of the French Senate "Tremplin Entreprises" contest.

In June 2009, NovoCIB concluded its first fund raising with members of the Savoie Angels association and its investment fund, Allobroges Participations.

Metabolys (September 2009)

Laureate in 2007 and 2009 of the national competition for the creation of enterprises with innovative technologies organized by the Ministry of Universities and Research, Metabolys has 2 complementary sectors of activity: on the one hand, it offers contract services for various industries and, on the other hand, it has the ambition to discover new antidiabetics at the preclinical development stage.

Imaxio (June 2009)

Imaxio is a biopharmaceutical company specialising in the fields of oncology and infectious diseases, for which the company develops and commercialises diagnostic and therapeutic products.

iDD biotech (April 2009)

Created in May 2008, iDD biotech is dedicated to the discovery and development of therapeutic monoclonal antibodies (MAb) for the treatment of cancer, autoimmune diseases or neurological disorders.

Edelris (March 2009)

Edelris is a medical chemistry research company based in Lyon, which develops innovative services for life sciences companies involved in new active principles discovery.

ERYtech Pharma (January 2009)

ERYtech Pharma develops a new generation of medicinal products: drugs entrapped into red blood cells (RBC).

Alizé Pharma (October 2008)

Founded in 2007, the Alizé Pharma Group is a group of biopharmaceutical companies specialized in the development of innovative therapeutics for the treatment of metabolic diseases and cancer.

Nano-h (September 2008)

Nano-h develops and uses a modern technology to produce news applications: nanopowders, hybrid particles and biological coated nanospheres of high quality in accordance with their customer's specifications. The company develops and manufactures functionalized Nanoparticles for life science and Hightech companies.